x

China approves arthritis drug for coronavirus treatment

An anti-inflammation drug, Actemra (tocilizumab), manufactured by the Swiss pharmaceutical company, Roche, has been approved by the Chinese government for the treatment of patients who are developing severe complications from coronavirus.

Actemra is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs.

Roche was quoted as saying that a third party has initiated the trial independently to explore the efficacy and safety of the drug in coronavirus patients with cytokine release syndrome (CRS).

According to the online portal, Pharmaceutical Technology, the latest development comes as China’s National Health Commission announced that it was searching for new ways to combat the deadly virus, which has so far killed 3,300 persons, alongside 96,414 infections in 84 countries and territories.

In its latest treatment guidelines published online, the Chinese commission said the biologic drug Actemra can now be used to treat coronavirus patients who have severe lung damage and high IL-6 levels.

The Interleukin-6 (IL-6) is a protein produced by various cells. It helps regulate immune responses, which makes the IL-6 test potentially useful as a marker of immune system activation. IL-6 can be elevated with inflammation, infection, autoimmune disorders, cardiovascular diseases, and some cancers.

In 2010, Actemra secured approval from the US Food and Drug Administration for the treatment of rheumatoid arthritis.

The drug is capable of inhibiting high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases, FDA had noted.

Researchers in China have also put the 10-year-old medication to a clinical trial, and are expected to enrol a total of 188 patients with Covid-19 on it.

Hot this week

Editors Urge Government To Create Safe, Enabling Environment For Journalists

· Ask security agents to find missing Vanguard journalist As...

EXCLUSIVE: Buhari orders probe of Isa Funtua, AMCON over keystone and Etisalat

Following the controversy generated by the leading opposition party,...

6 Signs your boyfriend thinks you are ugly -Take note of No. 2

They say there are three kinds of people; the...

2023: South-East, Middle Belt Forum Endorses Peter Obi

The South-East and Middle Belt Forum has endorsed the...

Verydarkman Reacts After Mercy Chinwo Follows Him on Instagram, Calls Her Out Over Past Dispute

Controversial social media activist, Verydarkman, has publicly criticized gospel...

BREAKING: Keyamo Inaugurates Ganduje as FAAN Board Chairman

Minister of Aviation and Aerospace Development, Festus Keyamo, has...

NIN Enrolment Hits 121 Million in Mid-2025 as NIMC Targets 95% National Coverage by Year-End

The National Identity Management Commission (NIMC) has recorded a...

NCSP DG Visits Ajaokuta Steel Company Ahead of Investors/Technical Partners’ Visit

As part of renewed efforts to revitalise Nigeria’s industrial...

NECO Opens 2025 SSCE External Registration, Sets September 18 Deadline

The National Examinations Council (NECO) has commenced registration for...

FCT Striking Primary Teachers, Insist “No Payment, No Work”

By Joyce Remi-Babayeju Striking primary school teachers in in the...

NCPC South South Zonal staff celebrate , Chief Weli Wosu

By Joyce Remi-Babayeju The staff of the Nigerian Christian Pilgrim...
spot_img

Related Articles

Popular Categories

spot_imgspot_img